Research Into the Molecular Bases of a New Phenotype Combining Premature White Hair, Polycystic Kidney Disease, Aortic Dilation/Dissection and Lymphopenia
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- New Phenotype (Combining Premature White Hair, Polycystic Kidney Disease, Aortic Dilation/Dissection and Lymphopenia)
- Sponsor
- Centre Hospitalier Universitaire Dijon
- Enrollment
- 4
- Locations
- 1
- Primary Endpoint
- Bcl-2-regulating miRNA sequencing
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
This study involves a single family, including 1 patient, father, mother and sister. The patient presented with a new phenotype associating premature white hair, renal polycystosis, aortic dilation/dissection and lymphopenia. Samples were taken in order to identify the origin of the symptomatology highlighted in the index case.
In addition, it was observed that mice invalidated for bcl-2, normal at birth and indistinguishable from control mice, showed, after one week, a phenotype similar to that observed in this patient.
The overlap between the patient's main clinical signs (lymphopenia, white hair and polycystic renal disease) and the manifestations presented by the invalidated murine model for BCL2 suggests that its phenotype may be secondary to a Bcl-2 expression defect.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Bcl-2-regulating miRNA sequencing
Time Frame: Through study completion, an average of 2 years.
Study of the methylation of the BCL2 promoter
Time Frame: Through study completion, an average of 2 years.
Whole genome sequencing of BCL2
Time Frame: Through study completion, an average of 2 years.